2024年7月2日,布里娜·莫拉莱斯出版
A new collaboration between The University of Texas MD Anderson Cancer Center and 莱斯大学 promises to drive industry growth and advance life-saving technologies through the newly established Cancer Bioengineering Collaborative.
The initiative will help foster collaboration between the two institutions on fundamental and translational cancer research, 开发癌症检测和治疗的新技术, 确保外部资金支持进一步的研究和培训. Rice researcher and Cancer Prevention and Research Institute of Texas (CPRIT) scholar Gang Bao and MD Anderson’s Dr. Jeffrey Molldrem将领导该中心.
“从癌症科学的基本发现, tumor immunology and patient care to innovative engineering advances in drug delivery systems, 纳米结构与合成生物学, there is great potential for enabling cross-disciplinary collaboration to develop new technologies and approaches for detecting, 监测和治疗癌症,“Molldrem, 造血生物学主席 & MD安德森的恶性肿瘤,在一份 释放. “Our goal is to bridge the gap between bioengineering and cancer research to create transformative solutions that significantly improve patient outcomes.”
该合作组织还将每月举办以癌症生物工程为重点的研讨会, annual retreats to highlight research and international leaders in cancer and bioengineering. 五个研究领域将成为该中心工作的核心:
A seed grant program will also be established to fund research projects in the early stages of development.
The partnership between Rice and MD Anderson is a testament to how the greater Houston region is committed to 推进生命科学和生物技术产业. 该地区最近出现了新的重大生命科学发展, 包括Levit Green, TMC螺旋公园和 位于伍德兰的亚历山大先进技术中心.
Stay up-to-date on what’s happening with the Partnership and Greater Houston region by opting-in to receive information on upcoming events, 新闻, 数据发布及更多.